BioSpace News Archive

Drug Development

Onconova Therapeutics Announces Data on Improved Formulation of Rigosertib and Next-Generation CDK4/6 Inhibitor at 2017 American Association of Pharmaceutical Scientists Annual Meeting

Three posters were presented at the American Association of Pharmaceutical Scientists Annual Meeting and Exposition, the world’s largest pharmaceutical sciences meeting, during November 14-15, 2017.

November 16, 2017

·

7 min read

Drug Development

Ultragenyx Announces Completion of Patient Dosing in First Cohort of Phase I/II Clinical Study of DTX301 Gene Therapy in Ornithine Transcarbamylase (OTC) Deficiency

Initial data from this first cohort of three patients is expected in early 2018.

November 16, 2017

·

4 min read

Business

Pernix Therapeutics Announces Election of Two Healthcare Industry Veterans to Board of Directors

The Company’s Board remains at five members, four of whom are independent, as incumbent directors.

November 16, 2017

·

5 min read

Prothena Highlights Breadth of Novel Pipeline at R&D Day

Prothena management will discuss progress on Prothena’s clinical and discovery programs.

November 16, 2017

·

6 min read

Drug Development

Innovation Pharmaceuticals Offers Perspectives on Brilacidin as a Potential Preventative Treatment for Oral Mucositis in Head and Neck Cancer Patients

The Phase 2 randomized, placebo-controlled clinical trial of Brilacidin-OM, enrolled a total of 61 patients.

November 16, 2017

·

8 min read

Biotech Beach

Cytori Reports Bioequivalence Trial Results in Ovarian Cancer at AAPS

The data was presented this week at the American Association of Pharmaceutical Scientists Annual Meeting held in San Diego and the abstract is available online.

November 16, 2017

·

4 min read

Business

BioAtla Appoints James Allison, Ph.D. and Padmanee Sharma, M.D., Ph.D. as Scientific Advisors

BioAtla today announced the appointments of James Allison, Ph.D., and Padmanee Sharma, M.D., Ph.D., as scientific advisors. Drs. Allison and Sharma are leading researchers in the field of immuno-oncology.

November 16, 2017

·

4 min read

Policy

Interpace Diagnostics Announces New York State Approval of New Product

The TERT marker is a strong molecular predictor of the aggressiveness of thyroid cancer and adds additional insights into a patient’s molecular profile.

November 16, 2017

·

6 min read

FDA

Sonoma Pharmaceuticals Announces FDA Approval of Expanded Indication for Alevicyn to Add Antimicrobial Language

The expanded approval is for the company’s Alevicyn Dermal Spray, to include antimicrobial language and antimicrobial data against clinically relevant microorganisms.

November 16, 2017

·

4 min read

Drug Development

KemPharm Completes Successful End-of-Phase II Meeting on KP415 With FDA

KemPharm held the EOP2 meeting with the FDA to discuss the status of the proposed clinical, non-clinical and abuse liability studies.

November 16, 2017

·

5 min read